Neomycin resistance as a dominant selectable marker for selection and isolation of vaccinia virus recombinants.

AUTOR(ES)

Franke, C A

RESUMO

The antibiotic G418 was shown to be an effective inhibitor of vaccinia virus replication when an appropriate concentration of it was added to cell monolayers 48 h before infection. Genetic engineering techniques were used in concert with DNA transfection protocols to construct vaccinia virus recombinants containing the neomycin resistance gene (neo) from transposon Tn5. These recombinants contained the neo gene linked in either the correct or incorrect orientation relative to the vaccinia virus 7.5-kilodalton gene promoter which is expressed constitutively throughout the course of infection. The vaccinia virus recombinant containing the chimeric neo gene in the proper orientation was able to grow and form plaques in the presence of G418, whereas both the wild-type and the recombinant virus with the neo gene in the opposite polarity were inhibited by more than 98%. The effect of G418 on virus growth may be mediated at least in part by selective inhibition of the synthesis of a subset of late viral proteins. These results are discussed with reference to using this system, the conferral of resistance to G418 with neo as a positive selectable marker, to facilitate constructing vaccinia virus recombinants which contain foreign genes of interest.

Documentos Relacionados

• Plaque size phenotype as a selectable marker to generate vaccinia virus recombinants.
• Neomycin resistance as a selectable marker in Methanococcus maripaludis.
• Isolation of influenza C virus recombinants.
• Antigenic subunits of Hantaan virus expressed by baculovirus and vaccinia virus recombinants.
• Protection of mice and swine from pseudorabies virus conferred by vaccinia virus-based recombinants.